News
Welcome to your daily round-up of everything happening in the world of neurorehabilitation - exclusively for our online members.
Did you know as an online member for just £2.99 a month (cancel anytime) you can read a daily snapshot of developments from across the world of neuro-rehab every day - spanning research, tech, company news and policy / legislation / society. You can also access in-depth, exclusive interviews and insights every week. Join now to make sure you're informed on all aspects of neuro-rehab.
The world of rehab medicine has been reminded that seemingly small improvements to interventions can make significant differences to goal attainment and outcomes.
New findings about how a long-trusted treatment for spasticity should be delivered have highlighted the importance of attention to detail in the pharmacological side of neuro-rehab.
Spasticity is experienced by around 34 per cent of stroke survivors within 18 months following a stroke. It can also be a result of spinal cord injury, MS, cerebral palsy, brain or head trauma and metabolic diseases.
It is usually caused by damage to parts of the brain or spinal cord that control voluntary movement. This leads to a change in the balance of signals between the nervous system and the muscles which leads to increased activity in the muscles. As a result, certain muscles are continuously contracted causing stiffness or tightness of the muscles which can interfere with normal movement, gait and speech.
Among treatment options for spasticity, is Dysport (abobotulinumtoxinA), an injectable form of botulinum neurotoxin type A product. It inhibits the effective transmission of nerve impulses, therefore reducing muscular contractions; and has more than 30 years of clinical experience and six million treatment years of patient experience.
But a major new study has highlighted widespread gaps in how such treatments are administered which have been found to have a detrimental on patients with neurological conditions.
In this article we interview lead researcher on the study, Dr Alberto Esquenazi, director of the Gait & Motion Analysis Laboratory at Jefferson Moss-Magee Rehabilitation in Philadelphia.
Find out about the inconsistencies he has discovered in the delivery of spasticity treatment, their impact on rehab outcomes and the reasons behind them; plus what he believes are the changes that need to happen in rehab medicine to address them.
Might 2024 be the year that we finally see football authorities take the lead in their battle to address the game’s harmful impact on the brain?
Given the decades in which the sport’s leaders have had to be dragged kicking and screaming into the neurological fight, perhaps that is optimistic.
Events are conspiring, however, to at least build momentum needed for change in football this year.
We speak to Jennifer Whittall about her journey into case management and the challenges and opportunities facing case managers today. Can you share your background and route into case management? I qualified as a chartered physiotherapist from the Oswestry school of physiotherapy based at the Robert Jones and Agnes Hunt Orthopaedic Hospital in Gobowen. The [...]
Through the tireless dedication of Carol Adcock, a specialist nurse at the Spinal Injuries Association, change is taking effect in frontline healthcare to help improve - and even save - the lives of SCI patients. NR Times meets selfless Carol, winner of the NR Times Above and Beyond Award 2023, sponsored by BIS Services, to learn [...]
With an ethos of maximising client achievement and potential, Westcountry Case Management is determined to make life after serious injury as fulfilling as it possibly can be - and, as part of that, regularly enables clients to go on holidays. Here, NR Times learns more about the approach of Westcountry - winner of Case Management [...]
Behind the scenes at Stewarts, winner of our Brain and Spinal Injury Law Firm of the Year 2023 award, sponsored by Chroma.
Litigation Nurse Manchester, England, United Kingdom (Remote) Full time We are currently recruiting for an experienced and talented individual to join our Clinical Support team, which is part of our award-winning Clinical Negligence team, as a Litigation Nurse in our brand new Manchester office. The role of the Litigation Nurse is to assist the [...]
St Andrew’s Healthcare has reached the final stages in four categories of a nationwide awards programme celebrating third sector organisations. St Andrew's is one of just three finalists shortlisted for the Compassion, Technology, Campaign for Change and the Development and Innovation categories at the annual Markel 3rd Sector Care Awards. The 3rd Sector Care Awards [...]
St Andrew's Healthcare is to host a free CPD Speech and Language webinar. Titled 'Navigating Communication and Emotional Arousal Levels: Principles and Practical Applications in Psychiatric Settings,' the webinar will take place on Wednesday March 6 from 1-2pm. Following significant interest from a recent NR Times article on SLT in Mental Health, join St Andrew's' Lead [...]
